EVerZom

EVerZom develops exosome-based therapies and a biomanufacturing platform for regenerative medicine. The company provides a technological value chain covering cell sourcing, exosome generation, loading, and formulation to produce drug candidates for digestive tissue healing and organ regeneration. Their pipeline includes treatments for Crohn’s fistula and liver and kidney repair, targeting the pharmaceutical industry and clinical-grade production.